Announcement on Change of Accounting Policies
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
The change is in accordance with new regulations issued by the Ministry of Finance of the People's Republic of China.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Guangzhou LBP Medicine Science & Technology Co., Ltd. on 6ix
Earlier from Guangzhou LBP Medicine Science & Technology
- Announcement on Voluntary Disclosure of Cervical Cell Digital Pathology Image Assisted Diagnosis Software Receiving Class III Medical Device Registration Certificate
- Announcement on the Estimated Amount of Daily Related Party Transactions in 2026
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Expected Loss in Performance for 2025
- Announcement on Shareholding Reduction Plan for Shareholders
Later from Guangzhou LBP Medicine Science & Technology
- Announcement on Voluntary Disclosure of Qualifications Obtained by Company and Subsidiary from January to March 2026
- Announcement on Canceling All Remaining Restricted Stocks in the 2022 Restricted Stock Incentive Plan
- Announcement on Result of Shareholding Reduction by Shareholders
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Implementation of Dividend Distribution for 2025
Follow Guangzhou LBP Medicine Science & Technology into a list and get an email when it puts out news.
Follow Guangzhou LBP Medicine Science & Technology